Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chet Villa
Observed name:
Chet S Villa
Institutions:
Cincinnati Children's Hospital Medical Center,
University of Cincinnati
Observed institutions:
Cincinnati Children's Hospital Medical Center,
University of Cincinnati
ORCID:
0000-0002-8195-0694
Observed ORCID:
0000-0002-8195-0694
OpenAlex ID:
A5135443134
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial
2026
·
Craig M McDonald
, Chet Villa
, et al.
·
The Lancet
·
3
Cardiac MRI in cardiac dystrophinopathy: recommendations on imaging
2026
·
Adam McDiarmid
, Daniel Augustine
, et al.
·
Open Heart
·
3
Prospective Multicenter Evaluation of a Novel Active Driving System for Pediatric Ventricular Assist Device Support
2026
·
Jonathan B. Edelson
, Matthew J. O’Connor
, et al.
·
Journal of the American College of Cardiology
·
2
From case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinicians
2026
·
Chelsea Murphy
, Nat Nasomyont
, et al.
·
Neuromuscular Disorders
·
2
PDF
Use of SGLT2 Inhibitors in Dystrophin Deficient Cardiomyopathy: A Multi-center Study Using the ACTION Registry
2026
·
Rachel E. Harris
, Carol A. Wittlieb-Weber
, et al.
·
Pediatric Cardiology
·
1
PDF
Repurposing Empagliflozin for Duchenne Muscular Dystrophy-Associated Cardiomyopathy: Protocol for a Pharmacokinetics, Safety and Proof-of-Concept Trial in Children
2026
·
Sebastiano A. G. Lava
, Craig Laurence
, et al.
·
Cardiology and Therapy
·
1
PDF
Fatal Fat Embolism Syndrome Without Recognized Fracture in Patients With Duchenne Muscular Dystrophy: Two Case Reports
2026
·
Cameron A. Wade
, Chet Villa
, et al.
·
Pediatric Neurology
·
1
Heart Transplantation and Ventricular Assist Device in Duchenne Muscular Dystrophy: A New Era
2025
·
David N. Rosenthal
, Antonio Amodeo
, et al.
·
Pediatric Transplantation
·
1
18O HOPE-3, a phase 3 study of deramiocel, an allogeneic cell therapy, in advanced Duchenne muscular dystrophy: evidence to support both musculoskeletal and cardiac efficacy
2026
·
Craig McDonald
, Chet Villa
, et al.
·
Neuromuscular Disorders
07O An interdisciplinary evaluation of the impact of GLP-1 receptor agonists in individuals with Duchenne muscular dystrophy
2026
·
Lily Deng
, Eleanor Greiner
, et al.
·
Neuromuscular Disorders
PDF
HeartMate 3 in Pediatric and Complex Populations: Physiologic Rationale, Patient Selection, and Management Strategies
2026
·
Tanya Perry
, Jon Edelson
, et al.
·
ASAIO Journal
Echocardiography in duchenne muscular dystrophy: a call for consistency and standardisation of reporting
2026
·
Lynne Williams
, Sadie Bennett
, et al.
·
Echo Research and Practice
PDF
A homozygous variant in cardiac troponin I3, TNNI3, causes severe pediatric restrictive cardiomyopathy
2026
·
Jirko Kühnisch
, Cara L. Barnett
, et al.
·
Human Genetics and Genomics Advances
1571 Autopsy Evaluation of the Patterns of Liver Pathology in Duchenne Muscular Dystrophy
2026
·
Kathryn Rice
, Lara Berklite
, et al.
·
Laboratory Investigation
Abstract 16814: Does Small Size Matter With Continuous Flow Devices: Analysis of the INTERMACS Database of Adults With BSA ≤1.5m2
2015
·
Farhan Zafar
, David L Morales
, et al.
·
Circulation
Show more works
View as search
Works count:
15
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type